Lv2
110 积分 2023-09-26 加入
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
2个月前
已完结
Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method
2个月前
已完结
Challenges and solutions for therapeuticTCR‐based agents
2个月前
已完结
In vitro hemolysis: Guidance for the pharmaceutical scientist
3个月前
已完结
A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer
3个月前
已完结
The landscape of T cell antigens for cancer immunotherapy
4个月前
已完结
Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors
5个月前
已完结
Bispecific antibodies for immune cell retargeting against cancer
5个月前
已完结
Development of a New BCMAxCD3 Duobody® Antibody for Multiple Myeloma
6个月前
已完结
Alpha and Beta Radiation for Theragnostics
6个月前
已完结
皖公网安备34019202002308
